Generic placeholder image

Current Diabetes Reviews

Author(s): Dalia N. Toaima, Mona H. El-Samahy, Osama K. Zaki, Yousef M. Elshami and Nadin N. Toaima*

DOI: 10.2174/1573399815666190718144722

DownloadDownload PDF Flyer Cite As
Effect of Estrogen Receptor- Alpha Gene Polymorphism (IVS1-397 T>C) on Microvascular Complications of Type 1 Diabetes Mellitus

Page: [770 - 778] Pages: 9

  • * (Excluding Mailing and Handling)

Abstract

Background: Type 1 diabetes mellitus (T1DM) is an autoimmune disease whose etiology involves genetic predisposition as well as environmental factors. Polymorphisms of some genes are among the most important genetic factors that influence autoimmunity. Gender is another important factor affecting autoimmunity. Females are more susceptible to autoimmune diseases which may be due to the effect of sex hormones on the immune system activity. The metabolic effects of estrogen are mediated through its receptor – alpha. The exact mechanism is not well understood. A number of polymorphisms have been reported in the Estrogen Receptor- alpha (ER-alpha) IVS1 397 T>C gene which may be involved in the pathogenesis of diabetes.

Objectives: To assess the influence of Estrogen Receptor- alpha gene [IVS1-397 T>C] polymorphism on vascular complications of type1 diabetes mellitus in pubertal females and on the glycemic control.

Methods: This cross-sectional case-control study included 40 pubertal regularly menstruating girls less than 18 years with type 1 diabetes mellitus recruited from the Pediatric Diabetes Clinic, Childrenʼs Hospital, Ain-Shams University and 20 healthy age-and sex-matched controls. Estrogen receptor alpha genotypes were analyzed by Restriction Fragment Length PCR and correlated with both clinical and laboratory parameters in the studied cases. ER-alpha was chosen as it might play a role in diabetes pathogenesis.

Results: The study revealed the TC genotype was the most prevalent genotype of the estrogen receptor. The TT genotype patients had a younger age of onset of T1DM. The prevalence of obesity was higher among TC and TT than in CC bearing patients. In addition, CC genotype patients had the least prevalence of microalbuminuria and had better glycemic control than other genotypes.

Conclusion: Our findings suggest that Estrogen receptor- alpha gene may be affecting the age of onset of Type1 diabetes mellitus in pubertal girls as well as the glycemic control of these patients, where CC bearing girls had better glycemic control than other genotypes and less incidence of microalbuminuria.

Keywords: Diabetes mellitus, puberty, girls, type 1, estrogen receptor- alpha, IVS1- 397 T>C.

[1]
Liese AD, D’Agostino RB Jr, Hamman RF, et al. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 2006; 118(4): 1510-8.
[http://dx.doi.org/10.1542/peds.2006-0690] [PMID: 17015542]
[2]
Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009; 373(9680): 2027-33.
[http://dx.doi.org/10.1016/S0140-6736(09)60568-7] [PMID: 19481249]
[3]
Slominski B, Mysliwska J. Estrogen receptor alpha gene polymorphism and vascular complications in girls with type 1 diabetes mellitus. Mol Cell Biochem 2018; 437(1-2): 153-61.
[PMID: 28634856]
[4]
Gregersen PK, Behrens TW. Genetics of autoimmune diseases--disorders of immune homeostasis. Nat Rev Genet 2006; 7(12): 917-28.
[http://dx.doi.org/10.1038/nrg1944] [PMID: 17139323]
[5]
Slominski Bartosz, Mysilwska J, Brandt A. Grade of inflammation in boys with type 1 diabetes depends on the IVS1-397T>C estrogen receptor alpha polymorphism. Journal of Diabet and its Compl 2015; 29(12): 801-7.
[6]
Ryba M, Malinowska E, Rybarczyk-Kapturska K, Brandt A, Myśliwiec M, Myśliwska J. The association of the IVS1-397T>C estrogen receptor α polymorphism with the regulatory conditions in longstanding type 1 diabetic girls. Mol Immunol 2011; 49(1-2): 324-8.
[http://dx.doi.org/10.1016/j.molimm.2011.09.004] [PMID: 21943781]
[7]
Tang L, Wang L, Liao Q, et al. Genetic associations with diabetes: meta-analyses of 10 candidate polymorphisms. PLoS One 2013; 8(7)e70301
[http://dx.doi.org/10.1371/journal.pone.0070301] [PMID: 23922971]
[8]
Codner E, Iniguez G, Lopez P, et al. Metformin for the treatment of hyperandrogenism in adolescents with type 1 diabetes mellitus: a double blind randomized study. Horm Res 2009; 72: 431.
[9]
Arrais RF, Dib SA. The hypothalamus-pituitary-ovary axis and type 1 diabetes mellitus: a mini review. Hum Reprod 2006; 21(2): 327-37.
[http://dx.doi.org/10.1093/humrep/dei353] [PMID: 16239312]
[10]
Kandiel MM, Watanabe G, Sosa GA, et al. Profiles of circulating steroid hormones, gonadotropins, immunoreactive inhibin and prolactin during pregnancy in goats and immunolocalization of inhibin subunits, steroidogenic enzymes and prolactin in the corpus luteum and placenta. J Reprod Dev 2010; 56(2): 243-50.
[http://dx.doi.org/10.1262/jrd.09-159S] [PMID: 20035106]
[11]
Cheung E, Schwabish MA, Kraus WL. Chromatin exposes intrinsic differences in the transcriptional activities of estrogen receptors α and β. EMBO J 2003; 22(3): 600-11.
[http://dx.doi.org/10.1093/emboj/cdg037] [PMID: 12554660]
[12]
Figtree , Noonan , Hindi , and Collins . Estrogen receptor polymorphisms: 2009.
[13]
Oshima Y, Matsuda K, Yoshida A, Watanabe N, Kawata M, Kubo T. Localization of estrogen receptors α and β in the articular surface of the rat femur. Acta Histochem Cytochem 2007; 40(1): 27-34.
[http://dx.doi.org/10.1267/ahc.06015] [PMID: 17375206]
[14]
Motawi TMK, El-Rehany MA, Rizk SM, Ramzy MM, El-Roby DM. Genetic polymorphism of estrogen receptor alpha gene in Egyptian women with type II diabetes mellitus. Meta Gene 2015; 6: 36-41.
[http://dx.doi.org/10.1016/j.mgene.2015.08.001] [PMID: 26401488]
[15]
Tanner JM. Normal growth and techniques of growth assessment. Clin Endocrinol Metab 1986; 15(3): 411-51.
[http://dx.doi.org/10.1016/S0300-595X(86)80005-6] [PMID: 3533329]
[16]
van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 2011; 91(1): 79-118.
[http://dx.doi.org/10.1152/physrev.00003.2010] [PMID: 21248163]
[17]
Taplin CE, Barker JM. Autoantibodies in type 1 diabetes. Autoimmunity 2008; 41(1): 11-8.
[http://dx.doi.org/10.1080/08916930701619169] [PMID: 18176860]
[18]
Quintero OL, Amador-Patarroyo MJ, Montoya-Ortiz G, Rojas-Villarraga A, Anaya JM. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 2012; 38(2-3): J109-19.
[http://dx.doi.org/10.1016/j.jaut.2011.10.003] [PMID: 22079680]
[19]
Ryba-Stanisławowska M, Rybarczyk-Kapturska K, Brandt A, Myśliwiec M, Myśliwska J. IVS1 -397T>C estrogen receptor α polymorphism is associated with low-grade systemic inflammatory response in type 1 diabetic girls. Mediators Inflamm 2014; 2014839585
[http://dx.doi.org/10.1155/2014/839585] [PMID: 24523574]
[20]
Codner E, Soto N, Lopez P, et al. Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2006; 91(6): 2250-6.
[http://dx.doi.org/10.1210/jc.2006-0108] [PMID: 16569737]
[21]
Spagnolo A, Giussani M, Ambruzzi AM, et al. Focus on prevention, diagnosis and treatment of hypertension in children and adolescents. Ital J Pediatr 2013; 39(1): 20.
[http://dx.doi.org/10.1186/1824-7288-39-20] [PMID: 23510329]
[22]
Ellis JA, Infantino T, Harrap SB. Sex-dependent association of blood pressure with oestrogen receptor genes ERalpha and ERbeta. J Hypertens 2004; 22(6): 1127-31.
[http://dx.doi.org/10.1097/00004872-200406000-00013] [PMID: 15167447]
[23]
Herrington DM, Howard TD, Brosnihan KB, et al. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 2002; 105(16): 1879-82.
[http://dx.doi.org/10.1161/01.CIR.0000016173.98826.88] [PMID: 11997270]
[24]
Rachoń D, Suchecka-Rachoń K, Hak Ł, Myśliwska J. Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women. Menopause 2006; 13(5): 840-5.
[PMID: 16894332]
[25]
Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 2005; 109(2): 143-59.
[http://dx.doi.org/10.1042/CS20050025] [PMID: 16033329]
[26]
Rohrer T, Stierkorb E, Grabert M, et al. Delayed menarche in young German women with type 1 diabetes mellitus: recent results from the DPV diabetes documentation and quality management system. Eur J Pediatr 2008; 167(7): 793-9.
[http://dx.doi.org/10.1007/s00431-007-0590-0] [PMID: 17763869]
[27]
Picardi A, Cipponeri E, Bizzarri C, Fallucca S, Guglielmi C, Pozzilli P. Menarche in type 1 diabetes is still delayed despite good metabolic control. Fertil Steril 2008; 90(5): 1875-7.
[http://dx.doi.org/10.1016/j.fertnstert.2007.09.035] [PMID: 18191849]
[28]
Schweiger BM, Snell-Bergeon JK, Roman R, McFann K, Klingensmith GJ. Menarche delay and menstrual irregularities persist in adolescents with type 1 diabetes. Reprod Biol Endocrinol 2011; 9: 61.
[http://dx.doi.org/10.1186/1477-7827-9-61] [PMID: 21548955]